ClassID:

95252

C07D403/12 - page 2 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#301
20250084067
2025-03-13

PYRAZOLE-SUBSTITUTED CYCLOPENTANOL ESTER DERIVATIVE AND USE THEREOF

#302
20250084040
2025-03-13

SUBSTITUTED HETEROCYCLES AS c-MYC TARGETING AGENTS

#303
20250082609
2025-03-13

HETEROCYCLIC SULFONAMIDE DERIVATIVES AND PHARMACEUTICAL USES THEREOF

#304
20250074898
2025-03-06

SOLID FORMS OF 2-(3,5-DICHLORO-4-((5-ISOPROPYL-6-OXO-1,6-DIHYDROPYRIDAZIN-3-YL)OXY)PHENYL)-3,5-DIOXO-2,3,4,5-TETRAHYDRO-1,2,4-TRIAZINE-6-CARBONITRILE

#305
20250074897
2025-03-06

PYRIDAZINONES AS PARP7 INHIBITORS

#306
20250074896
2025-03-06

ARYLTETRAHYDROPYRIDAZINE DERIVATIVE OR SALT THEREOF AND INSECTICIDAL AGENT CONTAINING THE COMPOUND AND METHOD FOR USING SAME

#307
20250074895
2025-03-06

CDK2 INHIBITORS AND METHODS OF MAKING AND USING SAME

#308
20250074888
2025-03-06

PYRIDAZINE DERIVATIVES AS MODULATORS OF NLRP3 INFLAMMASOME AND RELATED METHODS

#309
20250074874
2025-03-06

SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS

#310
20250073236
2025-03-06

PYRIMIDINE COMPOUNDS CONTAINING ACIDIC GROUPS

#311
20250066394
2025-02-27

3-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-yl DERIVATIVES

#312
20250066389
2025-02-27

HETEROCYCLIC AMIDES AND METHODS OF USING THE SAME

#313
20250066358
2025-02-27

Inhibitors of Menin-MLL Interaction

#314
20250066341
2025-02-27

CYCLOHEXANE ACID DERIVATIVES AS LPA RECEPTOR INHIBITORS

#315
20250066334
2025-02-27

SOLID STATE FORMS OF BELUMOSUDIL AND BELUMOSUDIL SALTS

#316
20250066333
2025-02-27

SOLID STATE FORMS OF BELUMOSUDIL AND BELUMOSUDIL SALTS

#317
20250066318
2025-02-27

HETEROCYCLIC COMPOUNDS AS DYRK1A INHIBITORS

#318
20250066309
2025-02-27

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

#319
20250066308
2025-02-27

BICYCLIC FUSED RING DERIVATIVE OR SALT THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

#320
20250059173
2025-02-20

CARDIAC SARCOMERE INHIBITORS

#321
20250059171
2025-02-20

ANTIVIRAL COMPOUNDS

#322
20250059160
2025-02-20

Chemical Activators of Nicotinamide Mononucleotide adenylyltransferase 2 (NMNAT2) and Uses Thereof

#323
20250059141
2025-02-20

TLR MODULATOR AND USE THEREOF

#324
20250057850
2025-02-20

ERBB/BTK INHIBITORS

#325
20250051286
2025-02-13

SMALL MOLECULE INHIBITORS OF PR3 AND HNE AND USES THEREOF

#326
20250051282
2025-02-13

COMPOUNDS FOR TREATING POLYQ-RELATED NEURODEGENERATIVE DISORDERS

#327
20250051277
2025-02-13

DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS

#328
20250051246
2025-02-13

Deuterated Antiviral Compounds

#329
20250049791
2025-02-13

Synthesis of MEK7 Inhibitors and methods of Use Thereof

#330
20250049772
2025-02-13

PIPERIDINYL-3-(ARYLOXY)PROPANAMIDES AND PROPANOATES

#331
20250042910
2025-02-06

HIV INHIBITOR COMPOUNDS

#332
20250042878
2025-02-06

INHIBITORS OF APOL1 AND METHODS OF USING SAME

#333
20250042862
2025-02-06

AROMATIC HETEROCYCLIC COMPOUND AND APPLICATION THEREOF

#334
20250034125
2025-01-30

COMPOUNDS AND USES THEREOF

#335
20250034124
2025-01-30

COMPOUNDS AND USES THEREOF

#336
20250034121
2025-01-30

COMPOUNDS AND THEIR USES AS GPR183 INHIBITORS

#337
20250034119
2025-01-30

COMPOUNDS, COMPOSITIONS, AND METHODS

#338
20250034118
2025-01-30

ANTIMALARIAL HEXAHYDROPYRIMIDINE DERIVATIVES

#339
20250032454
2025-01-30

KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE

#340
20250026763
2025-01-23

EGFR INHIBITORS AND METHODS OF USE THEREOF

#341
20250026759
2025-01-23

TETRAHYDROQUINAZOLINE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS

#342
20250026739
2025-01-23

COMPOUNDS AND RADIOLIGANDS FOR TARGETING NEUROTENSIN RECEPTOR AND USES THEREOF

#343
20250026730
2025-01-23

HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME

#344
20250026726
2025-01-23

QUINAZOLINONE DIONE COMPOUNDS AND USES THEREOF

#345
20250019364
2025-01-16

APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

#346
20250011344
2025-01-09

PRODRUGS AND DERIVATIVES OF PSILOCIN AND USES THEREOF

#347
20250011323
2025-01-09

MASP-2 INHIBITORS AND METHODS OF USE

#348
20250011304
2025-01-09

CRYSTALLINE FORM OF N-(2-CHLORO-3-((5-CHLORO-3-METHYL-4-OXO-3,4-DIHYDROQUINAZOLIN-6-YL)AMINO)-4-FLUOROPHENYL)-3-FLUOROAZETIDINE-1-SULFONAMIDE

#349
20250011300
2025-01-09

PIPERAZINYLSULFONYLARYL COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTIONS

#350
20250011299
2025-01-09

PYRIDAZINYL AMINO DERIVATIVES AS ALK5 INHIBITORS

#351
20250009742
2025-01-09

NOVEL CAPSID ASSEMBLY INHIBITORS

#352
20250002512
2025-01-02

NOVEL ANTI-DEPRESSANT AND NEUROPLASTIC AGENTS AND THERAPEUTIC USES THEREOF

#353
20250002455
2025-01-02

NEW N-PHENYLPYRROLAMIDE INHIBITORS OF DNA GYRASE AND TOPOISOMERASE IV WITH ANTIBACTERIAL ACTIVITY

#354
20240426833
2024-12-26

METHODS AND REAGENTS FOR ANALYZING PROTEIN-PROTEIN INTERFACES

#355
20240425547
2024-12-26

PSMA Imaging Agents

#356
20240425491
2024-12-26

HETEROARYL COMPOUNDS USEFUL IN THE TREATMENT OF COGNITIVE DISORDERS

#357
20240425486
2024-12-26

FUSED BICYCLIC SUBSTITUTED N-(1H-INDOL-7-YL)BENZENESULFONAMIDES AND USES THEREOF

#358
20240425484
2024-12-26

INHIBITORS OF TYK2

#359
20240425478
2024-12-26

CYCLOPENTYLPYRAZOLE CDK2 INHIBITORS

#360
20240425453
2024-12-26

ISOINDOLINES AS PMS2 INHIBITORS

#361
20240417396
2024-12-19

INHIBITORS OF TYK2

#362
20240417394
2024-12-19

NOVEL SUBSTITUTED PYRAZINE-CARBOXAMIDE DERIVATIVES

#363
20240417388
2024-12-19

BENZIMIDAZOLONE DERIVED INHIBITORS OF BCL6

#364
20240417379
2024-12-19

P2X4 RECEPTOR ANTAGONIST

#365
20240409580
2024-12-12

PSMA Imaging Agents

#366
20240409555
2024-12-12

CYANO CYCLOBUTYL COMPOUNDS FOR CBL-B INHIBITION AND USES THEREOF

#367
20240409533
2024-12-12

HMOX1 INDUCERS

#368
20240409518
2024-12-12

PARP INHIBITORS FOR TREATING CANCER AND ASTHMA

#369
20240409517
2024-12-12

ORGANIC COMPOUNDS

#370
20240408065
2024-12-12

CYANO COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF

#371
20240400591
2024-12-05

COMPOUNDS TARGETING MUTANT OF P53

#372
20240400577
2024-12-05

MODULATORS OF PROTEIN KINASES

#373
20240400553
2024-12-05

AMINE BASED MATRIPTASE 2 INHIBITORS AND USES THEREOF

#374
20240400543
2024-12-05

Methods for treating cancer

#375
20240400502
2024-12-05

SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME

#376
20240391920
2024-11-28

RING-MODIFIED PROLINE SHORT PEPTIDE COMPOUND AND USE THEREOF

#377
20240391917
2024-11-28

MASP-2 INHIBITORS AND METHODS OF USE

#378
20240391913
2024-11-28

SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4

#379
20240391909
2024-11-28

DISULFIDE COMPOUND, POLYSULFIDE COMPOUND, AND USE THEREOF

#380
20240391904
2024-11-28

DIHYDROPYRIMIDINE BASED COMPOUND, PREPARATION METHOD THEREFOR AND USE OF THEREOF

#381
20240391903
2024-11-28

AUTOTAXIN-INHIBITORS

#382
20240391882
2024-11-28

Substituted Quinoxalines

#383
20240391881
2024-11-28

PHARMACEUTICAL USE AND PREPARATION METHOD FOR SUBSTITUTED HETEROARYL PHTHALAZINE DERIVATIVE

#384
20240383923
2024-11-21

HETEROARYL DERIVATIVE AND USE THEREOF

#385
20240383910
2024-11-21

SMALL MOLECULE BTK DEGRADERS AND METHODS OF USE THEREOF

#386
20240382612
2024-11-21

BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF

#387
20240382486
2024-11-21

PYRIMIDINEDIONE COMPOUNDS

#388
20240382477
2024-11-21

NITROGEN-CONTAINING HETEROCYCLIC PYRIDINE COMPOUND

#389
20240381871
2024-11-21

5-HALOALKOXY-PYRIMIDINE COMPOUNDS AS HERBICIDES

#390
20240376117
2024-11-14

IMIDAZOLE-CONTAINING INHIBITORS OF ALK2 KINASE

#391
20240376114
2024-11-14

NUCLEAR TRANSPORT MODULATORS AND USES THEREOF

#392
20240376104
2024-11-14

Bcl-2 Inhibitors

#393
20240376093
2024-11-14

SULFOXIMINE COMPOUND AND USE THEREOF

#394
20240376085
2024-11-14

BENZIMIDAZOLES AS MODULATORS OF IL-17

#395
20240376084
2024-11-14

INHIBITORS OF ALPHA-HEMOLYSIN OF STAPHYLOCOCCUS AUREUS

#396
20240376080
2024-11-14

COMPOUND AS TYK2/JAK1 PSEUDOKINASE DOMAIN INHIBITOR, AND SYNTHESIS AND USE METHODS

#397
20240376079
2024-11-14

Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use Thereof

#398
20240376078
2024-11-14

METHODS AND COMPOSITIONS FOR TARGETING PD-L1

#399
20240376073
2024-11-14

QUATERNARY AMMONIUM CATION SUBSTITUTED COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS

#400
20240376059
2024-11-14

Compounds for the Treatment of Alzheimer's Disease

#401
20240376056
2024-11-14

PHENYL ACETAMIDE BASED IL-17A MODULATORS AND USES THEREOF

#402
20240374589
2024-11-14

PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE

#403
20240368184
2024-11-07

PIKfyve Inhibitors

#404
20240368137
2024-11-07

BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS

#405
20240368132
2024-11-07

ROCK2 INHIBITORS AND USES THEREOF

#406
20240368131
2024-11-07

OXOINDOLINYL AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF

#407
20240368130
2024-11-07

CRYSTAL FORMS OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3- (1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3) PYRIDAZINE-3-CARBOXAMIDE

#408
20240368129
2024-11-07

SULPHONYL UREA DERIVATIVES AS NLRP3 INFLAMMASOME MODULATORS

#409
20240368128
2024-11-07

PYRIDAZINONE AND METHODS OF USE THEREOF

#410
20240368123
2024-11-07

AROMATIC RING-CONTAINING BIOLOGICAL ANTAGONIST, AND PREPARATION METHOD THEREFOR AND USE THEREOF

#411
20240368122
2024-11-07

JAK2 INHIBITORS AND METHODS OF USE THEREOF

#412
20240368119
2024-11-07

RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME

#413
20240368118
2024-11-07

CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH

#414
20240368089
2024-11-07

AURORA KINASE AND JANUS KINASE INHIBITORS FOR PREVENTION OF GRAFT VERSUS HOST DISEASE

#415
20240366598
2024-11-07

GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR ANTAGONISTS AND USES THEREOF

#416
20240366536
2024-11-07

MODULATORS OF A POTASSIUM CHANNEL AND OF TRPV1 CHANNEL AND USES THEREOF

#417
20240360145
2024-10-31

PYRIMIDINE-2,4-DIAMINE DERIVATIVES AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF

#418
20240360104
2024-10-31

TRANSCRIPTIONAL ENHANCED ASSOCIATED DOMAIN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND USES THEREOF

#419
20240360085
2024-10-31

Glucose Uptake Inhibitors

#420
20240360083
2024-10-31

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

#421
20240352004
2024-10-24

STABLE SALT AND CRYSTAL FORMS OF 2-[3-({1-[2-(DIMETHYLAMINO)ETHYL]-2-(2,2-DIMETHYLPROPYL)-1H-1,3-BENZODIAZOL-5-YL}SULFONYL)AZETIDIN-1-YL]ETHAN-1-OL

#422
20240352000
2024-10-24

NOVEL PYRIMIDINE-2,4-DIAMINE DERIVATIVES, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER

#423
20240351997
2024-10-24

NOVEL PARP7 INHIBITOR AND USE THEREOF

#424
20240351988
2024-10-24

ARYL HYDROCARBON RECEPTOR MODULATORS AND THEIR USE IN THE TREATMENT OF DISEASES AND DISORDERS

#425
20240351984
2024-10-24

INDOLINE COMPOUNDS FOR INHIBITING KIF18A

#426
20240343716
2024-10-17

COMPOUNDS FOR PREVENTING, INHIBITING, OR TREATING CANCER, AIDS AND/OR PREMATURE AGING

#427
20240343712
2024-10-17

SOLID-STATE FORMS OF 2-(3-(4-(1H-INDAZOL-5-YLAMINO)QUINAZOLIN-2-YL)PHENOXY)-N-ISOPROPYLACETAMIDE METHANE SULFONIC ACID SALT

#428
20240343711
2024-10-17

1-PYRAZOLYL-3- (4- ((2 -ANILINOPYRIMIDIN- 4 - YL) OXY) NAPTHTHALEN- I - YL) UREAS AS P38 MAPKINASE INHIBITORS

#429
20240343707
2024-10-17

SUBSTITUTED PHENYL ETHYNYL PYRIMIDINES AS POTENT INHIBITORS OF ALPHAVIRUSES

#430
20240343706
2024-10-17

PIPERIDINE-2,6-DIONE DERIVATIVES WHICH BIND TO CEREBLON, AND METHODS OF USE THEREOF

#431
20240343694
2024-10-17

PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT

#432
20240336608
2024-10-10

IL4I1 INHIBITORS AND METHODS OF USE

#433
20240336606
2024-10-10

SUBSTITUTED BENZO OR PYRIDOPYRIMIDINE AMINE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

#434
20240336597
2024-10-10

PRODRUG OF PYRROLIDONE DERIVATIVES AS GLUCOKINASE ACTIVATOR

#435
20240336596
2024-10-10

PARP7 INHIBITOR AND USE THEREOF

#436
20240336574
2024-10-10

METHYL-SUBSTITUTED PYRIDINE AND PYRIDAZINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE

#437
20240335462
2024-10-10

SULFUR/PHOSPHORUS-CONTAINING ARYL COMPOUND AND APPLICATION THEREOF

#438
20240335427
2024-10-10

SMALL MOLECULE INHIBITION OF DEUBIQUITINATING ENZYME JOSEPHIN DOMAIN CONTAINING 1 (JOSD1) AS A TARGETED THERAPY FOR LEUKEMIAS WITH MUTANT JANUS KINASE 2 (JAK2)

#439
20240327393
2024-10-03

FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF

#440
20240327387
2024-10-03

TRIAZINE DERIVATIVES FOR THE TREATMENT OF TUMOURS AND NEURODEGENERATIVE DISORDERS

#441
20240327380
2024-10-03

BTK INHIBITORS

#442
20240327351
2024-10-03

AMIDE AND ETHER SUBSTITUTED N-(1H-INDOL-7-YL)BENZENESULFONAMIDES AND USES THEREOF

#443
20240327334
2024-10-03

Covalent Inhibitors As Antiviral Agents

#444
20240317732
2024-09-26

A NEW MOLECULAR SCAFFOLD FOR TARGETING HRPN13

#445
20240317719
2024-09-26

Compounds useful for treating gastrointestinal tract disorders

#446
20240317718
2024-09-26

SUBSTITUTED HETEROCYCLIC COMPOUNDS

#447
20240317717
2024-09-26

SULFONAMIDE COMPOUNDS AND THE USE THEREOF IN THE TREATMENT OF CANCER

#448
20240317713
2024-09-26

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

#449
20240316038
2024-09-26

APOL1 INHIBITORS AND METHODS OF USE

#450
20240316022
2024-09-26

INDAZOLE COMPOUNDS

#451
20240316017
2024-09-26

NOVEL PYRIDINE DERIVATIVE COMPOUND AS RON INHIBITOR

#452
20240308984
2024-09-19

Jak Inhibitor With High Oral Bioavailability

#453
20240307419
2024-09-19

CONFORMATIONALLY-CONSTRAINED INHIBITORS OF 3C OR 3C-LIKE PROTEASES

#454
20240300905
2024-09-12

Quinazoline Compounds and Uses

#455
20240299357
2024-09-12

PHARMACEUTICAL COMBINATION, COMPOSITION AND COMPOUND PREPARATION COMPRISING GLUCOKINASE ACTIVATOR AND DPP-IV INHIBITOR, AND PREPARATION METHOD AND USE THEREOF

#456
20240294524
2024-09-05

HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS

#457
20240294509
2024-09-05

PYRIDAZINONE COMPOUND AS PARP7 INHIBITOR

#458
20240294507
2024-09-05

ADDITIVE FOR IMPARTING ULTRAVIOLET ABSORBENCY AND/OR HIGH REFRACTIVE INDEX TO MATRIX, AND RESIN MEMBER USING SAME

#459
20240294506
2024-09-05

CDK2 INHIBITORS

#460
20240293416
2024-09-05

TREATMENT OF LIVER DISORDERS WITH A THR-ß AGONIST

#461
20240293386
2024-09-05

NOVEL COMPOUND AS PROTEIN KINASE INHIBITOR

#462
20240293380
2024-09-05

PROTEASE INHIBITORS AND METHODS OF USE

#463
20240292840
2024-09-05

TRIAZOLE COMPOUNDS FOR THE CONTROL OF INVERTEBRATE PESTS

#464
20240287058
2024-08-29

PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF

#465
20240287050
2024-08-29

(4-(6-((2-OCTAHYDROCYCLOPENTA[C]PYRROL-5-YL)AMINO)PYRIDAZIN-3-YL)PHENYL)(IMINO)(METHYL)-LAMBDA6- SULFANONE DERIVATIVES AND SIMILAR COMPOUNDS AS MUSCARINIC ACETYLCHOLINE RECEPTOR M4 ANTAGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

#466
20240287046
2024-08-29

Compounds and radioligands for targeting neurotensin receptor and uses thereof

#467
20240287045
2024-08-29

CRYSTAL FORM OF PYRIMIDINE DERIVATIVE AND PREPARATION METHOD THEREFOR

#468
20240287044
2024-08-29

SALT OF SELECTIVE FGFR4 INHIBITOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#469
20240287043
2024-08-29

KETOAMIDE DERIVATIVE AND APPLICATION THEREOF

#470
20240285808
2024-08-29

MOLECULAR PROBES FOR IN VIVO DETECTION OF ALDEHYDES

#471
20240285614
2024-08-29

PHENOL RIBONUCLEOTIDE REDUCTASE (RNR) INHIBITORS AND USES THEREOF

#472
20240285598
2024-08-29

COMPOUNDS FOR THE TREATMENT OF SARS

#473
20240279220
2024-08-22

INDOLE COMPOUNDS AND METHODS OF USE

#474
20240279205
2024-08-22

NOVEL BENZIMIDAZOLE DERIVATIVE

#475
20240279204
2024-08-22

NOVEL DIPHENAZINE COMPOUND, AND USE THEREOF FOR PREVENTING OR TREATING CANCER OR NEUROINFLAMMATORY DISEASES

#476
20240279201
2024-08-22

DUAL WNT SIGNALING PATHWAY INHIBITORS AND AMPK ACTIVATORS FOR TREATMENTS OF DISEASE

#477
20240279188
2024-08-22

Hydrazide containing nuclear transport modulators and uses thereof

#478
20240279187
2024-08-22

COMPOUNDS, DEVICES, AND USES THEREOF

#479
20240279174
2024-08-22

ANTIBIOTICS COMPRISING LPXH-TARGETING COMPOUNDS AND METHODS OF MAKING AND USING THE SAME

#480
20240270750
2024-08-15

IMIDAZOLE-CONTAINING INHIBITORS OF ALK2 KINASE

#481
20240270722
2024-08-15

POLO LIKE KINASE 4 INHIBITORS

#482
20240270721
2024-08-15

INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF

#483
20240270699
2024-08-15

COMPOUNDS HAVING N-ARYLPYRIMIDIN-2-AMINE DERIVATIVES AS THERAPEUTIC AGENTS

#484
20240269113
2024-08-15

3-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-yl DERIVATIVES

#485
20240262829
2024-08-08

PEPTIDE NUCLEIC ACIDS, SYNTHESIS, AND USES THEREOF

#486
20240262817
2024-08-08

QUINAZOLINE DERIVATIVES TARGETING R(CCUG) REPEATS IN MYOTONIC DYSTROPHY TYPE 2

#487
20240262813
2024-08-08

NEW SELECTIVE ANGIOTENSIN II COMPOUNDS

#488
20240262810
2024-08-08

Belumosudil Metabolites and Uses Thereof In The Treatment of Chronic Graft-Versus-Host Disease

#489
20240262806
2024-08-08

INHIBITORS OF NLRP3

#490
20240262793
2024-08-08

QUINAZOLINE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#491
20240261416
2024-08-08

SYNTHESIS OF NOVEL CEREBLON E3 LIGASE LIGANDS, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

#492
20240254109
2024-08-01

SALT CONTAINING PIPERAZINE POLYCYCLIC DERIVATIVE, CRYSTAL FORM THEREOF, PREPARATION METHOD THEREFOR, AND USE THEREOF

#493
20240254089
2024-08-01

MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS

#494
20240246954
2024-07-25

COMPOSITIONS AND METHODS FOR INHIBITING KRAS

#495
20240246950
2024-07-25

Anilino-Pyrazole Derivatives, Compositions and Methods Thereof

#496
20240246944
2024-07-25

AMINO HETEROARYL COMPOUNDS AND COMPOSITIONS

#497
20240246943
2024-07-25

MULTIFACETED APPROACH TO NOVEL INTERLEUKIN-6 INHIBITORS

#498
20240246940
2024-07-25

HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF

#499
20240246939
2024-07-25

INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF

#500
20240246934
2024-07-25

QUINAZOLINE-BASED COMPOUND, COMPOSITION, AND APPLICATION OF QUINAZOLINE-BASED COMPOUND

#501
20240246932
2024-07-25

ARYL 3-OXOPIPERAZINE CARBOXAMIDES AND HETEROARYL 3-OXOPIPERAZINE CARBOXAMIDES AS NAV1.8 INHIBITORS

#502
20240246931
2024-07-25

COMPOUNDS AS PD1/PD-L1 INHIBITORS AND METHODS THEREOF

#503
20240246920
2024-07-25

TRIAZOLE DERIVATIVES WITH ANTIFUNGAL ACTIVITY

#504
20240246909
2024-07-25

EBNA1 Inhibitors and Methods Using Same

#505
20240246908
2024-07-25

TEAD INHIBITORS

#506
20240246902
2024-07-25

PRODRUGS OF 6-DIAZO-5-OXO-L-NORLEUCINE

#507
20240245673
2024-07-25

Papain-like protease (PLpro) inhibitors

#508
20240239806
2024-07-18

COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISORDERS

#509
20240239784
2024-07-18

INDOLE COMPOUNDS AND METHODS OF USE

#510
20240239772
2024-07-18

PROTEASE INHIBITORS AND METHODS OF USE

#511
20240239771
2024-07-18

BACTERIAL EFFLUX PUMP INHIBITORS

#512
20240239770
2024-07-18

ALLYL-CONTAINING BISPHENOL RESIN

#513
20240239758
2024-07-18

SUBSTITUTED TRIAZINE COMPOUND

#514
20240239757
2024-07-18

PHTHALAZINONE DERIVATES AS NLRP3 INFLAMMASOME INHIBITORS

#515
20240239755
2024-07-18

SUBSTITUTED PYRIDAZINONES, SALTS OR N-OXIDES THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES

#516
20240228468
2024-07-11

N-(6-((OCTAHYDROCYCLOPENTA[C]PYRROL-5-YI)AMINO)PYRIDAZIN-3-YL)PHENYL)CARBOXAMIDE AND (6- ((OCTAHYDROCYCLOPENTA[C]PYRROL-5-YL)AMINO)PYRIDAZIN-3-YL)BENZAMIDE DERIVATIVES AS MACHR M4 ANTAGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

#517
20240228446
2024-07-11

PREPARATION METHOD FOR BICYCLIC COMPOUND AND APPLICATION AS ANTIFUNGAL AGENT

#518
20240226106
2024-07-11

INHIBITORS OF PLASMA KALLIKREIN

#519
20240226098
2024-07-11

COMPOUNDS AND METHODS FOR MODULATING SPLICING

#520
20240217968
2024-07-04

PHARMACEUTICAL COMPOUND

#521
20240217930
2024-07-04

SARS-COV-2 MPRO INHIBITOR COMPOUNDS

#522
20240216386
2024-07-04

MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE

#523
20240208969
2024-06-27

SUBSTITUTED FUSED BICYCLIC COMPOUNDS AS PARP INHIBITORS AND THE USE THEREOF

#524
20240208946
2024-06-27

FUNCTIONALIZED MATERIALS AND COMPOUNDS

#525
20240208945
2024-06-27

6-CARBAMATE SUBSTITUTED HETEROARYL RING DERIVATIVES

#526
20240208944
2024-06-27

Quinazoline Derivatives, Pharmaceutical Compositions, and Therapeutic Uses Related to Nox Inhibition

#527
20240208943
2024-06-27

POLYMORPHS OF SELINEXOR

#528
20240208934
2024-06-27

ULK1/2 INHIBITORS AND THEIR USE THEREOF

#529
20240208927
2024-06-27

WNT SIGNALING PATHWAY INHIBITORS FOR TREATMENTS OF DISEASE

#530
20240207425
2024-06-27

AURISTATIN LINKER-PAYLOADS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

#531
20240206209
2024-06-20

Light-Emitting Element, Display Device, Electronic Device, and Lighting Device

#532
20240199641
2024-06-20

QUINAZOLINE-4(3H)-ONE DERIVATIVES AS NEGATIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2

#533
20240199640
2024-06-20

NEGATIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2

#534
20240199596
2024-06-20

DIACYLGLYCEROL KINASE MODULATING COMPOUNDS

#535
20240199591
2024-06-20

SELECTIVE LIGANDS FOR MODULATION OF GIRK CHANNELS

#536
20240199585
2024-06-20

SOLID FORMS OF (3R)-N-[2-CYANO-4-FLUORO-3-(3-METHYL-4-OXO-QUINAZOLIN-6-YL)OXY-PHENYL]-3-FLUORO-PYRROLIDINE-1-SULFONAMIDE

#537
20240199584
2024-06-20

KRAS INHIBITORS

#538
20240199583
2024-06-20

ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS

#539
20240199577
2024-06-20

ACORAMIDIS ANALOGS FOR STABILIZING TRANSTHYRETIN AND INHIBITING TRANSTHYRETIN MISFOLDING

#540
20240199555
2024-06-20

APPLICATIONS OF BIASED LIGANDS OF THE SEROTONIN 5-HT7 RECEPTOR FOR THE TREATMENT OF PAIN, MULTIPLE SCLEROSIS AND THE CONTROL OF THERMOREGULATION

#541
20240199554
2024-06-20

Inhibitors of receptor interacting protein kinase I for the treatment of disease

#542
20240199546
2024-06-20

INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF

#543
20240199542
2024-06-20

SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES

#544
20240197752
2024-06-20

SUBSTITUTED QUINAZOLINES FOR INHIBITING KINASE ACTIVITY

#545
20240190855
2024-06-13

CDK INHIBITORS AND METHODS OF USE THEREOF

#546
20240190848
2024-06-13

INHIBITORS OF LRRK2 KINASE

#547
20240190846
2024-06-13

Thyroid hormone receptor agonists and use thereof

#548
20240190845
2024-06-13

CRYSTAL FORMS OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE

#549
20240190844
2024-06-13

PYRIDAZINONES AS PARP7 INHIBITORS

#550
20240190827
2024-06-13

Inhibitors of Rho Associated Coiled-Coil Containing Protein Kinase

#551
20240190826
2024-06-13

Novel Host-Targeted Pan-Respiratory Antiviral Small Molecule Therapeutics

#552
20240190821
2024-06-13

SULFONAMIDE SUBSTITUTED N-(1H-INDOL-7-YL)BENZENESULFONAMIDES AND USES THEREOF

#553
20240182475
2024-06-06

METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH HYPERMINERALIZATION

#554
20240182467
2024-06-06

INHIBITORS OF RAF KINASES

#555
20240182453
2024-06-06

NOVEL SUBSTITUTED PYRAZINE-CARBOXAMIDE DERIVATIVES

#556
20240182444
2024-06-06

ANTI-VIRAL COMPOUNDS

#557
20240182429
2024-06-06

HETEROCYCLIC COMPOUND AS TYK2 PSEUDOKINASE DOMAIN INHIBITOR, SYNTHETIC METHOD, AND USE

#558
20240181066
2024-06-06

Anti-cancer nuclear hormone receptor-targeting compounds

#559
20240180916
2024-06-06

Theramutein modultors

#560
20240174685
2024-05-30

OX2R Compounds

#561
20240174679
2024-05-30

HETEROAROYL AMIDES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

#562
20240174676
2024-05-30

Pyrazolopyrimidine compounds as kinase Inhibitors

#563
20240174675
2024-05-30

SMALL MOLECULE REGULATORS OF ALVEOLAR TYPE 2 CELL PROLIFERATION FOR THE TREATMENT OF PULMONARY DISEASES

#564
20240174665
2024-05-30

CDK2 INHIBITORS AND USES THEREOF

#565
20240174648
2024-05-30

Small Molecule Compound

#566
20240174647
2024-05-30

KINASE MODULATORS AND METHODS OF USE THEREOF

#567
20240174646
2024-05-30

METHYLLACTAM RING COMPOUND AND PHARMACEUTICAL USE THEREOF

#568
20240174643
2024-05-30

SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS

#569
20240166663
2024-05-23

NOVEL PYRIMIDINE DERIVATIVE SHOWING INHIBITION EFFECT ON GROWTH OF CANCER CELLS

#570
20240166631
2024-05-23

COMPOUND, METHOD FOR PRODUCING AND METHOD FOR STORING COMPOUND, METHOD FOR PRODUCING TARGETING AGENT, AND COMPOSITION

#571
20240166598
2024-05-23

COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THE SAME

#572
20240158414
2024-05-16

BI-ARYL DIHYDROOROTATE DEHYDROGENASE INHIBITORS

#573
20240158403
2024-05-16

SMALL MOLECULE MYRISTATE INHIBITORS OF BCR-ABL AND METHODS OF USE

#574
20240158389
2024-05-16

Pyrimidine compound as JAK kinase inhibitor

#575
20240158383
2024-05-16

RIBONUCLEOTIDE REDUCTASE (RNR) INHIBITORS AND USES THEREOF

#576
20240158373
2024-05-16

RING-MODIFIED PROLINE SHORT PEPTIDE COMPOUND AND USE THEREOF

#577
20240158372
2024-05-16

BISAMIDE SARCOMERE ACTIVATING COMPOUNDS AND USES THEREOF

#578
20240158371
2024-05-16

PROCESS FOR THE PREPARATION OF PYRIMIDINYL-4-AMINOPYRAZOLE COMPOUNDS

#579
20240158356
2024-05-16

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

#580
20240150376
2024-05-09

Compounds, Compositions and Methods

#581
20240150368
2024-05-09

ULK INHIBITORS AND METHODS OF USE THEREOF

#582
20240150326
2024-05-09

CARBOXAMIDE COMPOUNDS AND USES THEREOF

#583
20240150325
2024-05-09

NOVEL COMPOUND AS PROTEIN KINASE INHIBITORS

#584
20240150324
2024-05-09

5-membered heteroaryl carboxamide compounds for treatment of HBV

#585
20240150320
2024-05-09

Quaternary indazole glucocorticoid receptor antagonists

#586
20240150318
2024-05-09

PROTEASE INHIBITORS FOR TREATMENT OF CORONAVIRUS INFECTIONS

#587
20240150297
2024-05-09

NOVEL COMPOUNDS COMPRISING A NEW CLASS OF TRANSTHYRETIN LIGANDS FOR TREATMENT OF COMMON AGE-RELATED COMORBIDITIES

#588
20240150296
2024-05-09

Human plasma kallikrein inhibitors

#589
20240150295
2024-05-09

Human plasma kallikrein inhibitors

#590
20240150284
2024-05-09

Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for their Preparation and Therapeutic Uses Thereof

#591
20240148744
2024-05-09

SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES

#592
20240148742
2024-05-09

METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF

#593
20240148721
2024-05-09

DISCRETE PEG CONSTRUCTS

#594
20240140940
2024-05-02

CARBOXYLIC ACID, ACYL SULFONAMIDE AND ACYL SULFAMIDE-DERIVATIZED BICYCLIC AZA-HETEROAROMATICS AS SELECTIVE MCL-1 INHIBITORS AND AS DUAL MCL-1/BCL-2 INHIBITORS

#595
20240140935
2024-05-02

NON-COVALENT DIMER CATION, SALT THEREOF, PREPARATION METHOD THEREOF, AND USE THEREOF AS ANTIOXIDANT

#596
20240140909
2024-05-02

HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS

#597
20240139194
2024-05-02

PREPARATION AND METHODS OF USE FOR ORTHO-ARYL 5-MEMBERED HETEROARYL-CARBOXAMIDE CONTAINING MULTI-TARGETED KINASE INHIBITORS

#598
20240132499
2024-04-25

FUSED PYRROLINES WHICH ACT AS UBIQUITIN-SPECIFIC PROTEASE 30 (USP30) INHIBITORS

#599
20240132480
2024-04-25

INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS LIPOAMIDE DEHYDROGENASE

#600
20240132475
2024-04-25

SUBSTITUTED PYRAZOLYL COMPOUNDS AS MALT-1 INHIBITORS